Clinical Trials Browser

Unknown × Neoplasms × Docetaxel × Clear all

NCT05094804 2023-11-02

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Leiomyosarcoma, Liposarcoma, Melanoma, Neoplasm Metastasis, Neoplasms

NCT03402048 2020-11-04

EPIC

Phase 3 Unknown

567 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT01611961 2014-09-30

Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients

Phase 1 Unknown

35 enrolled

Tumor-Agnostic

Neoplasms

NCT00845884 2009-02-18

Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer

Phase 1/2 Unknown

49 enrolled

Tumor-Agnostic

Neoplasms

NCT00415285 2007-02-13

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

Phase 2 Unknown

100 enrolled

Breast

Breast Neoplasms, Neoplasms